Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic rats.

Feigh M, Hjuler ST, Andreassen KV, Gydesen S, Ottosen I, Henriksen JE, Beck-Nielsen H, Christiansen C, Karsdal MA, Henriksen K.

Eur J Pharmacol. 2014 Aug 15;737:91-6. doi: 10.1016/j.ejphar.2014.05.016. Epub 2014 May 22.

PMID:
24858364
2.

A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet-induced obese rats.

Feigh M, Henriksen K, Andreassen KV, Hansen C, Henriksen JE, Beck-Nielsen H, Christiansen C, Karsdal MA.

Diabetes Obes Metab. 2011 Oct;13(10):911-20. doi: 10.1111/j.1463-1326.2011.01425.x.

PMID:
21615667
3.

Oral salmon calcitonin improves fasting and postprandial glycemic control in lean healthy rats.

Feigh M, Nielsen RH, Hansen C, Henriksen K, Christiansen C, Karsdal MA.

Horm Metab Res. 2012 Feb;44(2):130-4. doi: 10.1055/s-0031-1298027. Epub 2011 Dec 23.

PMID:
22198815
4.

Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta-cell area and function in Zucker diabetic fatty rats.

Feigh M, Andreassen KV, Neutzsky-Wulff AV, Petersen ST, Hansen C, Bay-Jensen AC, Henriksen JE, Beck-Nielsen H, Christiansen C, Henriksen K, Karsdal MA.

Br J Pharmacol. 2012 Sep;167(1):151-63. doi: 10.1111/j.1476-5381.2012.01979.x.

5.

Oral salmon calcitonin protects against impaired fasting glycemia, glucose intolerance, and obesity induced by high-fat diet and ovariectomy in rats.

Feigh M, Andreassen KV, Hjuler ST, Nielsen RH, Christiansen C, Henriksen K, Karsdal MA.

Menopause. 2013 Jul;20(7):785-94. doi: 10.1097/GME.0b013e31827c58ab.

PMID:
23793169
6.

A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in rats.

Andreassen KV, Feigh M, Hjuler ST, Gydesen S, Henriksen JE, Beck-Nielsen H, Christiansen C, Karsdal MA, Henriksen K.

Am J Physiol Endocrinol Metab. 2014 Jul 1;307(1):E24-33. doi: 10.1152/ajpendo.00121.2014. Epub 2014 May 6.

7.

Oral salmon calcitonin protects against impaired fasting glycemia, glucose intolerance, and obesity induced by high-fat diet and ovariectomy in rats.

Feigh M, Andreassen KV, Hjuler ST, Nielsen RH, Christiansen C, Henriksen K, Karsdal MA.

Menopause. 2013 Feb 4. [Epub ahead of print]

PMID:
23385715
8.

Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.

Wang Y, Campbell T, Perry B, Beaurepaire C, Qin L.

Metabolism. 2011 Feb;60(2):298-305. doi: 10.1016/j.metabol.2010.02.005. Epub 2010 Mar 20.

PMID:
20304443
9.

Natural product vindoline stimulates insulin secretion and efficiently ameliorates glucose homeostasis in diabetic murine models.

Yao XG, Chen F, Li P, Quan L, Chen J, Yu L, Ding H, Li C, Chen L, Gao Z, Wan P, Hu L, Jiang H, Shen X.

J Ethnopharmacol. 2013 Oct 28;150(1):285-97. doi: 10.1016/j.jep.2013.08.043. Epub 2013 Sep 5.

PMID:
24012527
10.

Effects of intermittent intraperitoneal infusion of salmon calcitonin on food intake and adiposity in obese rats.

Chelikani PK, Haver AC, Reidelberger RD.

Am J Physiol Regul Integr Comp Physiol. 2007 Nov;293(5):R1798-808. Epub 2007 Aug 29.

11.

Effect of sleeve gastrectomy on body weight, food intake, glucose tolerance, and metabolic hormone level in two different rat models: Goto-Kakizaki and diet-induced obese rat.

Trung VN, Yamamoto H, Yamaguchi T, Murata S, Akabori H, Ugi S, Maegawa H, Tani T.

J Surg Res. 2013 Nov;185(1):159-65. doi: 10.1016/j.jss.2013.05.019. Epub 2013 May 28.

PMID:
23746960
12.

Tyrosol, a phenolic compound, ameliorates hyperglycemia by regulating key enzymes of carbohydrate metabolism in streptozotocin induced diabetic rats.

Chandramohan R, Pari L, Rathinam A, Sheikh BA.

Chem Biol Interact. 2015 Mar 5;229:44-54. doi: 10.1016/j.cbi.2015.01.026. Epub 2015 Jan 29.

PMID:
25641191
13.
14.

Improvement of impaired glucose tolerance by oral administration of vanadyl sulfate by gavage in streptozotocin-induced diabetic rats.

Tsunajima T, Tatsuki R, Satoh K, Yamamoto A, Hoshi K, Ichihara K.

Res Commun Mol Pathol Pharmacol. 1997 Nov;98(2):190-200.

PMID:
9467827
15.

Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.

Sullivan TJ, Miao Z, Zhao BN, Ertl LS, Wang Y, Krasinski A, Walters MJ, Powers JP, Dairaghi DJ, Baumgart T, Seitz LC, Berahovich RD, Schall TJ, Jaen JC.

Metabolism. 2013 Nov;62(11):1623-32. doi: 10.1016/j.metabol.2013.06.008. Epub 2013 Aug 15.

PMID:
23953944
16.

Studies on hypoglycaemic effects of polyherbal preparation in streptozotocin-induced diabetic male albino rats.

Ismail Khan A, Yuvaraj S, Suthagar E, Parthasarathy C, Balasubramanian K.

Hum Exp Toxicol. 2009 Nov;28(11):679-87. doi: 10.1177/0960327109106969. Epub 2009 Sep 15.

PMID:
19755436
17.

Oral administration of sodium tungstate improves cardiac performance in streptozotocin-induced diabetic rats.

Nagareddy PR, Vasudevan H, McNeill JH.

Can J Physiol Pharmacol. 2005 May;83(5):405-11.

PMID:
15897922
18.

KBP-042 improves bodyweight and glucose homeostasis with indices of increased insulin sensitivity irrespective of route of administration.

Hjuler ST, Andreassen KV, Gydesen S, Karsdal MA, Henriksen K.

Eur J Pharmacol. 2015 Sep 5;762:229-38. doi: 10.1016/j.ejphar.2015.05.051. Epub 2015 May 28.

PMID:
26027795
19.

Two novel glucagon receptor antagonists prove effective therapeutic agents in high-fat-fed and obese diabetic mice.

O'Harte FP, Franklin ZJ, Irwin N.

Diabetes Obes Metab. 2014 Dec;16(12):1214-22. doi: 10.1111/dom.12360. Epub 2014 Aug 19.

PMID:
25060150
20.

Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats.

Qinna NA, Badwan AA.

Drug Des Devel Ther. 2015 May 5;9:2515-25. doi: 10.2147/DDDT.S79885. eCollection 2015.

Supplemental Content

Support Center